Shockwave Therapy • Regenerative Medicine • Practice Growth
What if a non-invasive treatment service could help your medical practice address the needs of appropriate musculoskeletal patients while opening the door to a new revenue stream?
In this episode of Meet the Experts, host JR Burgess welcomes Joel Suraci, Founder and CEO of RegenTx, to spotlight the clinical and business considerations behind the growing interest in shockwave therapy.
Discover the differences between focused shockwave therapy and radial pressure wave technology, why provider education matters, and what medical practices should evaluate before introducing a new device, treatment protocol, or cash-pay service.
The Shockwave Opportunity: Technology With a Purpose
Musculoskeletal pain, mobility concerns, and soft-tissue conditions are important parts of care for many regenerative, orthopedic, sports medicine, and wellness practices. Shockwave technology is one modality that providers may consider for selected clinical indications.
But successful implementation takes more than purchasing a device. It requires careful patient selection, understanding the technology, clinical training, realistic outcome expectations, and a sustainable service model.
Joel brings nearly two decades of experience supporting physicians in regenerative medicine, orthobiologics, and musculoskeletal care. Through RegenTx, his focus includes science-backed equipment, education, and ongoing clinical support.
What You’ll Explore
- The opportunity for shockwave services in appropriate medical practices
- How focused shockwave and radial pressure wave technologies differ
- Potential musculoskeletal applications and the importance of evidence
- Questions to ask before choosing a shockwave system
- Why physician education and hands-on training matter
- How imaging, orthobiologics, and shockwave may fit within broader care
- Planning a cash-pay service without assuming guaranteed revenue
- The role of ongoing support, protocols, and outcome tracking
Key takeaway: Start with the patient and the evidence. Then choose the technology, training, and business model that make sense for your practice.
Technology, Training & Practice Integration
Focused Shockwave Technology
Focused shockwave devices concentrate acoustic energy at a defined treatment depth. RegenTx features the PiezoWave2T platform. Appropriate use depends on the condition, device specifications, clinician training, and applicable indications.
Radial Pressure Wave Technology
Radial devices distribute pressure-wave energy over broader, generally more superficial areas. RegenTx offers the EMS Dolorclast system, giving practices another modality to evaluate for suitable musculoskeletal applications.
Education & Ongoing Support
RegenTx also works with ultrasound imaging, orthobiologics, clinical training, and implementation support. The objective is not simply to add equipment, but to equip a care team to use appropriate technologies responsibly.
A Smarter Path to Launching Shockwave Services
EVALUATE
Identify appropriate patient needs, clinical indications, available evidence, device differences, and financial feasibility.
IMPLEMENT
Select the right technology, train the clinical team, establish protocols, and define how the service fits the patient journey.
OPTIMIZE
Track outcomes, patient experience, utilization, and service-line performance; refine the offering as evidence and experience evolve.
Clinical note: Shockwave evidence and appropriate treatment protocols vary by condition and device. Confirm indications, risks, training requirements, and applicable regulations before implementation. Treatment outcomes and financial returns are not guaranteed.
Connect With Joel Suraci & RegenTx
Explore Shockwave Technology for Your Practice
Considering focused shockwave or radial pressure wave therapy? RegenTx provides access to medical technologies, educational resources, and support for practices evaluating regenerative and musculoskeletal treatment options.
Connect with Joel Suraci and the RegenTx team to discuss systems, training, and the considerations specific to your clinical setting.
Email: info@regentxmedical.com | Phone: 888-586-4866
Meet the Experts
Joel Suraci
Founder & CEO | RegenTx, Inc.
Joel Suraci has worked with physicians and medical practices in regenerative medicine, orthobiologics, and musculoskeletal care for nearly two decades. His expertise includes evaluating the science, performance, and clinical applications of regenerative technologies—with particular interest in platelet-rich plasma (PRP), bone marrow concentrate, microfragmented fat, imaging, and shockwave technologies.
Through RegenTx, Joel supports providers with technology selection, education, hands-on training, and ongoing guidance intended to help practices make informed, evidence-based decisions.
Contact: info@regentxmedical.com | 888-586-4866
JR Burgess
Executive Business Advisor | MD Business Advisors
JR Burgess is an Executive Business Advisor and healthcare growth strategist who helps doctors build thriving cash-based clinics with stronger systems, better teams, and measurable patient outcomes.
Having served in fractional leadership roles spanning CEO, COO, CFO, CRO, and CMO responsibilities, JR brings hands-on experience across the major functions of clinic growth. He helps medical professionals move beyond clinical education into leadership, implementation, scalability, and sustainable business growth.
